Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
Charan Yerasi, Brian C. Case, Chava Chezar‐Azerrad, Brian J. Forrestal, Giorgio A. Medranda, Corey Shea, Cheng Zhang, Itsik Ben‐Dor, Lowell F. Satler, Nelson L. Bernardo, Hayder Hashim, Héctor M. García‐García, Ron Waksman
Topics & Concepts
CangrelorMedicineConventional PCIPercutaneous coronary interventionCardiologyInternal medicineAnesthesiaMyocardial infarctionP2Y12Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchHeparin-Induced Thrombocytopenia and Thrombosis